HHHikaru Hashimura

Hikaru Hashimura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hikaru Hashimura has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Jimmy Shen

    Department of Endocrinology, Monash Health , Clayton, VIC 3168 , Australia

    2 shared publications
  • Jun Yang

    Department of Medicine, Monash University, Clayton, Victoria, Australia (J.Y.).

    2 shared publications
  • Winston Chong

    Department of Imaging, Monash Health , Clayton, VIC 3168 , Australia

    2 shared publications
  • Hiroki Kobayashi

    Department of Internal Medicine, Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine , Tokyo 102-8275 , Japan

    1 shared publication
  • James C G Doery

    Department of Medicine, Monash University , Clayton, VIC 3168 , Australia

    1 shared publication
  • James C. G. Doery

    Department of Pathology, Monash Health, Clayton, Vic., Australia

    1 shared publication

Latest Publications

  • Open Access

    Saline suppression to distinguish the primary aldosteronism subtype: a diagnostic study

    by Hikaru Hashimura, Jinbo Hu, Hiroki Kobayashi, Stella May Gwini, Jimmy Shen, Nicholas Y N Chee, James C G Doery, Winston Chong, Peter J Fuller, Masanori Abe, et al.

    The saline suppression test (SST) serves to confirm the diagnosis of primary aldosteronism (PA), while adrenal vein sampling (AVS) is used to subtype PA as unilateral or bilateral. Criteria that can accurately identify those with bilateral PA based on SST results could reduce the need for AVS. We previously demonstrated that a combination of plasma aldosterone concentration (PAC) < 300 pmol L−1 and a reduction in aldosterone-to-renin ratio (ARR) following recumbent SST had high specificity for predicting bilateral PA in an Australian cohort of 92 patients with PA who have undergone AVS. We sought to validate our predictive criteria in larger, independent cohorts of patients with PA. An international, multi-centre cohort study. Data from 55 patients at Monash Health, Victoria, Australia, 106 patients from the First Affiliated Hospital of Chongqing Medical University, China, and 105 patients from Nihon University Itabashi Hospital, Japan were analysed. A combination of PAC −1 and a reduction in ARR following recumbent SST predicted bilateral PA with specificities of 88.2%, 97.0%, and 100.0% in Australian, Chinese, and Japanese cohorts, respectively. This criterion could allow 22%–38% of patients with PA to bypass AVS and proceed directly to medical treatment. In patients undergoing the recumbent SST, a post-saline PAC −1 together with a reduction in ARR can predict bilateral PA with high specificity and may allow targeted treatment to be commenced without AVS in up to a third of patients.


  • Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism

    by Hikaru Hashimura, Jimmy Shen, Peter J. Fuller, Nicholas Y. N. Chee, James C. G. Doery, Winston Chong, Kay Weng Choy, Stella May Gwini, Jun Yang

    Summary: Background: The saline suppression test (SST) serves to confirm the diagnosis of primary aldosteronism (PA) whilst adrenal vein sampling (AVS) is used to determine whether the aldosterone hypersecretion is unilateral or bilateral. An accurate prediction of bilateral PA based on SST results could reduce the need for AVS.Aim: We sought to identify SST parameters that reliably predict bilateral PA.Methods: The results from 121 patients undergoing SSTs at Monash Health from January 2010 to January 2018 including screening blood tests, imaging, AVS and histopathology results were evaluated. Patients were subtyped into unilateral or bilateral PA based on AVS and surgical outcomes.Results: Of 113 patients with confirmed PA, 33 had unilateral disease whilst 42 had bilateral disease. In those with bilateral disease, plasma aldosterone concentration (PAC) was significantly lower post‐SST, together with a significant fall in the aldosterone‐renin ratio (ARR). The combination of PAC < 300 pmol/L and a reduction in ARR post‐SST provided 96.8% specificity in predicting bilateral disease. Eighteen of 39 patients (49%) with bilateral PA could have avoided AVS using these criteria.Conclusion: A combination of PAC < 300 pmol/L and a lower ARR post‐SST could reliably predict bilateral PA. An independent cohort will be needed to validate these findings.